Since MYC expression is strongly induced by ER activation (Fig. 6a and Supplementary Fig. 7a)17,18, our results suggest that SCRIB is regulated by the ER-MYC pathway in ER+ breast cancer cells. Here, SCRIB is linked to breast carcinoma.